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Background: Oral lichen planus (OLP) is one of the most common dermatological diseases which are present in 
the oral cavity. It is a chronic autoimmune, mucocutaneous disease that affects the oral mucosa as well as the skin, 
genital mucosa and other sites. Objective: review the relevant information to OLP and its relationship with systemic 
diseases. 
Material and Methods: searches were carried out in the Medline/PubMed, Lilacs, Bireme, BVS, and SciELO da-
tabases by using key-words. After an initial search that provided us with 243 papers, this number was reduced to 
78 from the last seven years. One of the first criteria adopted was a selective reading of the abstracts of articles for 
the elimination of publications that presented less information regarding the subject proposed for this work. All 
the selected articles were read in their entirety by all of the authors, who came to a consensus about their level of 
evidence. The Scottish Intercollegiate Guidelines Network (SIGN) criteria were used as the criteria of methodolo-
gical validation. 
Results: Only 9 articles showed an evidence level of 1+, 2+, 3 or 4, as well as a recommendation level of A, B, C or 
D. Three of them were non-systematic reviews, one was a cohort study and only one was a controlled clinical trial. 
Three of the studies were case series, with respective sample sizes of 45, 171 and 633 patients. 
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Introduction
Lichen planus (LP) is a chronic inflammatory mucocu-
taneous disease that evolves in outbreaks, affecting the 
skin, mucous membranes or both. It is recurrent and of 
unknown etiology (1). It tends to adopt different mor-
phologies and experience unpredictable periods of re-
mission and exacerbation (2). It is the dermatological 
disease that most often presents oral manifestations (3). 
The exclusive oral presentation of the disease occurs 
in one out of every three patients, with the three most 
frequent locations of the buccal mucosa, the tongue and 
gums (2-4). Oral lichen planus (OLP) may adopt diffe-
rent clinical forms (5,6) and the presentations can be 
singular or combined. Each one of them has specific fea-
tures. Its manifestations typically persist for years at a 
time, alternating between periods of latency and periods 
of exacerbation (7).
The etiology of this disease remains unknown, but va-
rious causal factors have been associated to this disease, 
among such factors are: anxiety, diabetes, autoimmune 
diseases, mainly chronic liver disease, intestinal disea-
ses, increased cholesterol, medications, stress, hyper-
tension, infections, contact with dental materials, can-
cer and a genetic predisposition to cancer (2,3,8-10). 
Therefore, the diagnosis of OLP must be based on the 
recognition of the clinical manifestations, as well as the 
performance of anamnesis in search of a possible cause 
and effect relationship (7,11). Finally, a histopathologi-
cal study must be performed in order to enable us to con-
firm the diagnosis (7).
Based on what has been previously stated, the aim of 
this paper is to review the information that is relevant 
to oral lichen planus and its relationship with systemic 




Searches were carried out in the Medline/PubMed, Li-
lacs, Bireme, BVS, and SciELO databases by using the 
words: oral lichen planus and systemic diseases, oral 
lichen planus and hepatitis C virus, diabetes and oral 
lichen planus, autoimmune diseases and oral lichen pla-
nus, chronic diseases and oral lichen planus, intestinal 
disease and oral lichen planus, cholesterol and oral li-
Conclusions: Several factors have been associated with OLP. Patients with OLP are carriers of a disease with systemic 
implications and may need the care of a multidisciplinary team. The correct diagnosis of any pathology is critical to 
making effective treatment and minimizes iatrogenic harm. For OLP is no different, taking into account its association 
with numerous systemic diseases that require special attention from health professionals. Periodic follow-up of all 
patients with OLP is recommended.
Key words: Oral lichen planus, etiopathogenesis, systemic diseases. 
chen planus, medications and oral lichen planus, hyper-
tension and oral lichen planus, anxiety and oral lichen 
planus, stress and oral lichen planus, infections and oral 
lichen planus in the title and/or abstract. One of the first 
criteria adopted was a selective reading of the abstracts 
of articles for the elimination of publications that pre-
sented less information regarding the subject proposed 
for this work.
-Selection, Inclusion Criteria, Data Extraction and As-
sessment of quality
After an initial search that provided us with 243 papers, 
this number was reduced to 78 from the last seven years. 
From there, we used the inclusion criteria of “English 
and free full text” which gave us a total of 22 papers. 
These 22 were read in their entirety by all of the authors, 
who came to a consensus about their level of evidence. 
Those that were not considered relevant to this review 
by two or more authors were discarded. The Scottish In-
tercollegiate Guidelines Network (SIGN) criteria were 
used as the criteria of methodological validation (12).
Results
Only 9 of the 22 articles that were reviewed showed an 
evidence level of 1+, 2+, 3 or 4, as well as a recommen-
dation level of A, B, C or D (Table 1, 1 continue). Three 
of them were non-systematic reviews, one was a cohort 
study and only one was a controlled clinical trial. Three 
of the studies were case series, with respective sample 
sizes of 45, 171 and 633 patients. 
Discussion
For the discussion of the reviewed literature we will use 
the papers referenced in Table 1 as well as bibliography 
of prior interest. We will review the most relevant as-
pects based on: i) concept and epidemiology, ii) clinical 
features, iii) etiology and iv) the relationship with sys-
temic diseases.
-Concept and Epidemiology
Lichen planus is a chronic inflammatory dermatosis of 
autoimmune origin that usually manifests in the oral mu-
cosa. The exact prevalence of OLP is unknown, however 
different sources report a prevalence of between 0.2% and 
5% (13), without racial predominance (14). For every one 
man, 3 or 4 women are diagnosed with the disease (14), 
but despite the higher prevalence among women, no link 
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has been found as justification. The hormonal changes 
caused by the climacteric do not appear to influence its 
onset, nor the clinical type (15). The typical age range for 
the manifestation of this disease is between 30 and 70, but 
cases have been reported in children (16,17).
-Clinical Features
The typical clinical findings related to OLP, especially 
the presence of a reticular, bilateral and symmetrical 
pattern, are normally deemed sufficient for the clinical 
diagnosis of the disease (7). A biopsy allows us to con-
firm the presumptive clinical diagnosis, also permitting 
us to rule out areas with signs of cellular atypia and ma-
lignancy, which is an aspect that is incompatible with the 
diagnosis of lichen planus (7). 
From a histological perspective, the disease presents a 
band-like inflammatory infiltrate in the papillary cho-
rion, hyperkeratosis with ortho- and/or parakeratosis and 
basal layer vacuolation degeneration of the epithelium. 
All of this leads us to believe that the critical pheno-
menon in the pathogenesis of this disease is a type of 
immune aggression directed towards the basal cells of 
the epithelium (11,18-21).
In regard to its possible malignant transformation, this 
topic is still controversial (3,11,21). In numerous series 
such possibility has been proven, although the risk is low 
(1,6,11,22,23). By modifying some of the above-mentio-
ned criteria, Warnakulasuriya et al. (24), in 2007 included 
OLP as a potentially malignant alteration and the majority 
of authors recommended the monitoring of these patients 
for an indefinite period of time, with the aim of early de-
tection of its possible malignization (6,11,21).
Mucosal lesions appear with a fine white reticular pattern 
(Wickham’s striae), or white papules, in 50-60% of pa-
tients. The most frequent manifestation is in the oral and 
genital mucosa, however lesions can also appear on the 
skin, scalp, nails, esophagus and eyes (13). It is important 
to remember that nearly 82% of patients do not show any 
symptoms, or they report non-specific discomfort such as 
roughness or a feeling of dryness in the oral mucosa. This 
implies that the the lesions are many times not perceived 
by the patient. In most cases the patients are diagnosed 
for the first time during a routine dental visit. Only 18% 
of patients experience pain, especially if the lesions are 
atrophic-erosive, extensive and severe (25).
The lesions are considered atrophic and erosive when 
they affect the gingiva, and they typically present a clini-
cal pattern known as “chronic desquamative gingivitis” 
(CDG) (26,27). However, CDG is a non-specific process 
that may appear in other mucocutaneous diseases, some 
of which are very relevant, such as cicatricial pemphi-
goid and pemphigus vulgaris (26). In a study conducted 
by Bermejo-Fenoll et al. (27), in 2010, 314 OLP patients 
(57.1%) out of a total of 550 had gingival involvement. 
In their results, 17.5% of women presented desquamati-
ve gingivitis, as opposed to 4.7% of men. Mignogna et 
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al. (28), in 2000, on the other hand, observed a series of 
723 patients with OLP, and identified 336 (48%) cases of 
gingival involvement, out of which a total of 24 (7.4%) 
showed severe symptoms. 
-Etiology
The etiology of lichen planus remains unknown. The 
existence of a family history can suggest a possible ge-
netic predisposition (29). Gene polymorphisms of diffe-
rent HLA markers, as well as inflammatory cytokines 
and chemokines have been associated with the presence 
of LP. The cause of these polymorphisms, although it is 
not clear, supports the autoantigen hypothesis (13). Di-
fferent authors have linked the onset, development and 
relapse of OLP, to stress, anxiety and depression (30,31). 
In the pathogenesis there are also phenomenon involved 
that are of immunological nature, systemic diseases like 
diabetes, hypertension and chronic liver disease, mainly 
hepatitis C (14,25,31-33); all of which will be detailed in 
the following section.
-Relationship with Systemic Diseases
Many studies that have been carried out over the last 
few years have focused on the relationship between 
OLP and the hepatitis C virus (HCV) (4,14,25,33,34). 
Research studies performed in Spain (35), the USA (36), 
Italy (28), Japan (37), China (38) and Brazil (4,39) have 
found a significantly greater prevalence of the HCV 
infection in patients with OLP when compared to the 
control groups. Lodi et al. (2010) (34) published a me-
ta-analysis and in their review they confirmed the asso-
ciation between the HCV infection and lichen planus. 
Based on this research, patients with LP have a risk that 
is approximately five times greater than that of the con-
trol groups for HCV seropositivity, but if we only focus 
on patients with OLP, the results are not significant (34). 
Another interesting fact is that the results that demons-
trate this strong association are usually found in geogra-
phical areas that are considered hyper endemic areas of 
HCV. No association has been found in geographical 
areas with low prevalence of HCV, like India, where a 
prevalence of 1.8% has been reported (40,41). The ge-
neral prevalence of liver disease in lichen planus is from 
0.1% to 35%, with a greater prevalence in patients that 
are in their 50s. In these patients the erosive variant of 
OLP is predominant (52%) and the most reported form 
of hepatitis is the chronic active presentation (42). The 
pathogenesis for this association is not clear, but it could 
be due to the cell-mediated cytotoxicity. Thus, the study 
performed by Femiano and Scully (2005) (43) suggests 
the possibility that HCV exerts an indirect effect through 
the induction of cytokines and lymphokines. Tovaru et 
al. (2013) (44), in a study in which 633 patients with 
OLP were evaluated, as well as the relationship with li-
ver profiles, found that 24% of the patients with lichen 
planus showed some type of liver anomaly, and of this 
group, 9.64% were affected by the hepatitis C virus.  In 
2006, Lodi (45) carried out a review including data rela-
ting to HCV in patients with OLP and he reported high 
rates of prevalence of HCV in individuals with OLP. 
There was a significant relationship between HCV in-
fection and manifestation of OLP found by De Carli et 
al. (2016) in a study carried out in Southern Brazil. Age, 
sex, systemic diseases and drugs were not identified as 
risk factors for the development of these diseases (4).
The association between lichen planus and cardiovas-
cular risk factors is related to chronic systemic inflam-
mation (46-49). On the other hand, the link between oral 
lichen planus and dyslipidemia seems to pique the inte-
rest of researchers. Various research studies have found 
a greater prevalence of dyslipidemia in patients with LP, 
and such studies therefore indicate that the patients with 
the disease should undergo analytical evaluations (46-
49). We must also remember that the presence of dysli-
pidemia in addition to other risk factors such as hyper-
tension, diabetes mellitus, smoking and kidney disease 
is very frequent and such factors increase cardiovascular 
events (46). Lopez-Jornet et al., in 2013 (50) assessed 
130 patients with OLP, they found that these patients pre-
dominantly suffered from diseases of the musculoskele-
tal system (22.3%), followed by anxiety and depression 
(21.5%). Hypertension was observed in 19.2% of the 
cases, while diabetes type 2 was found in 11.5%.  The 
hypercholesterolemia was found in the 11.5% of patients 
and hypothyroidism in just 1.5%. The authors sought the 
association between OLP and autoimmune diseases, but 
their results did not concur with the previous hypothesis.
The possible link between celiac disease and OLP is bac-
ked by Jokinen et al. (1998) (51), in their study carried out 
in 1998. In their research they reveal that of the 39 OLP 
patients, 22 presented CD positive antibodies. However, 
Scully et al. (1993) (52) did not diagnose celiac disease in 
any of the 103 patients that were studied, concluding that 
the association might just be accidental.
As of many years ago it has been suggested that the 
patients with OLP showed a greater incidence of dia-
betes than that of the general population (53). The link 
between OLP and diabetes is controversial, since more 
than one author (53,54) has indicated that an altered res-
ponse to the oral administration of glucose exists in pa-
tients with LP; since some glycemia curves and insulin 
responses were obtained that are comparable to the ones 
that appear in type 2 diabetes. In reference to this matter, 
Giménez-García and Pérez-Castrillón (2004) (55) found 
that 10% of the patients assessed in their study were 
diagnosed with diabetes mellitus and 30% reported a fa-
mily history of diabetes. We have already mentioned the 
study by Tovaru et al., in 2013 (44) where they assessed 
633 patients with OLP, out of which 10% presented ca-
ses of type 2 diabetes. Lundström (1983) (56) found that 
28% of the patients with OLP were diabetic, meanwhile 
in the group of individuals without OLP, only 3% suffe-
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red from diabetes. However, Munde et al. (2013) (57), 
found that only 2.4% of their series presented cases of 
DM. In the population with DM the incidence of lichen 
planus was 1.6% (58).
The importance that is attributed to psychological fac-
tors varies according to the authors. There is controversy 
about whether or not psychiatric disorders are involved 
in the genesis of the disease or if it is the result of the pre-
sence of chronic painful lesions. In the controlled study 
carried out by, Hirota et al. (2013) (59) the influence of 
psychological disorders (anxiety and depression) in oral 
lichen planus was evaluated. The results did not seem to 
support the idea that anxiety or depression have a role 
in the development of OLP lesions (59). Rojo-Moreno 
et al. (1998) (30), linked the most symptomatic erosive 
forms of OLP to stress and anxiety, these authors conclu-
ded that patients with oral lichen planus seem to suffer 
from a greater degree of anxiety and depression. Anxie-
ty or emotional factors would be capable of making the 
disease chronic, or influencing the apparition of clinical 
forms that are predominantly red, more symptomatic 
and more complicated to manage for the clinician (60). 
Therefore, besides being a possible risk factor, the psy-
chosomatic factors could aggravate the lesions (61). The 
results of the study carried out by Blanco-Carrión (2002) 
(31) reflect that psychosomatic alterations, hypercholes-
terolemia, diabetes and liver disease are frequently asso-
ciated with patients with OLP. 8.4% of the patients had 
cutaneous lesions. All of these associations were more 
frequent in the red clinical forms of oral lichen planus. 
Anxiety, depression and somatization presented higher 
values than in the control group; however anxiety had 
significantly higher values in patients with red lichen. 
On the other hand, patients with lichen planus reported 
frequent worsening of their disease throughout periods 
of stress (7). A study carried out in 1996 by Burkhart et 
al. (1996) (62) proved that 51.4% of the patients with 
OLP perceived stressful situations in their lives, related 
to work, personal relationships and losses, which were 
alterations that occurred before and during the progres-
sion of the disease. In this regard, the authors proposed 
the idea of a link between stress and OLP (62). In 2009, 
Pokupec et al. (63), concluded that specialized attention 
might be necessary for patients with concomitant psy-
chopathology with respect to lichen planus, particularly 
those with symptoms of depression, stress and anxiety.
Conclusions
Oral lichen planus is a chronic mucocuteaneous disease 
with multifactorial etiology and pathogenesis. Several 
factors have been associated with OLP. Its association 
with HCV and other diseases that tend to be linked to LP 
is controversial and in need of further research.
Clinically speaking, the disease undergoes periods of re-
mission and exacerbation and all patients must be properly 
monitored. Periodic follow-up of all patients with OLP is 
recommended. Patients with OLP are carriers of a disease 
with systemic implications and may need the care of a mul-
tidisciplinary team. The correct diagnosis of any pathology 
is critical to making effective treatment and minimizes ia-
trogenic harm. For OLP is no different, taking into account 
its association with numerous systemic diseases that requi-
re special attention from health professionals.
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